Skip to main content
Log in

Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease

  • Regular Papers
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Summary

Splenectomy in children with the Norrbottnian type of Gaucher disease is followed by increased blood levels of glucosylceramide and imparied neurological and mental status. High blood levels are associated with an increased accumulation of glucosylceramide in perivascular Gaucher cells in the brain compared to non-splenectomised cases. Surrounding the Gaucher cell infiltrates there is loss of neurons and slight demyelinaton in the brain parenchyma. The brains of four cases with the Norrbottnian type of Gaucher disease were examined by immunohistochemical stains in an attempt to further characterize the perivascular Gaucher cells and to examine the reactions of the vessel walls and brain parenchyma to the accumulation of Gaucher cells. The perivascular storage cells showed granular staining with antibodies to muramidase and α1-antichymotrypsin confirming that they are blood-derived macrophages belonging to the monocyte-macrophage system. The Gaucher cells contained material positive for antisera to plasma proteins strongly suggesting that large molecules (including glucosylceramide) can escape from the blood and be taken up by the macrophages in Gaucher disease. The storage cells were surrounded by a reticulin network stained by antisera to collagen type III, type IV and laminin. The infiltrates were bounded from the brain parenchyma by a membrane strongly positive with antiserum for the basal lamina protein collagen type IV and laminin. The formation of a basal lamina around the Gaucher cell cuffs probably constitutes a protective phenomenon governing the brain parenchyma against the foreign cells. A focal loss of neurons but only minor loss of axons could be demonstrated with the antiserum to neurofilament. The brain parenchyma surrounding the Gaucher cell infiltrates showed marked astrogliosis in the anti-glial fibrillary acidic protein stain.

In the two cases previously shown to have higher blood levels of glucosylceramide there were astrocytes positive for plasma proteins indicating passage of plasma proteins into the brain, this was not seen in the non-splenectomised cases. The additive effect of low-grade tissue damage in the vicinity of the Gaucher cell infiltrates is probably enough to explain the increased neurological symptoms and mental retardation following splenectomy in the Norrbottnian type of Gaucher disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adachi M, Wallace BJ, Schneck L, Volk BW (1967) Fine structure of central nervouse system in early infantile Gaucher's disease. Arch Pathol 83:513–526

    Google Scholar 

  2. Blom S, Erikson A (1983) Gaucher disease — Norrbottnian type. Neurodevelopmental, neurological and neurophysiological aspects. Eur J Pediatr 140:316–322

    Google Scholar 

  3. Brady RO, Barranger JA (1983) Glucosylceramide lipidosis: Gaucher's disease. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease, 4th edn. McGraw-Hill, New York, pp 842–856

    Google Scholar 

  4. Conradi NG, Sourander P, Nilsson O, Svennerholm L, Erikson A (1984) Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies. Acta Neuropathol (Berl) 65:99–109

    Google Scholar 

  5. Dreborg S, Erikson A, Hagberg B (1980) Gaucher disease —Norrbottnian type. I. General clinical description. Eur J Pediatr 133:107–118

    Google Scholar 

  6. Fredrickson DS, Slona HR (1972) Glucosylceramide lipidosis: Gaucher's disease. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The metabolic basis of inherited disease, 3rd edn. McGraw-Hill, New York, pp 730–759

    Google Scholar 

  7. Kalimo H, Lehto M, Näntö-Salonen K, Jalkanen M, Risteli L, Risteli J, Narva EV (1985) Characterization of the perivascular reticulin network in a case of primary brain lymphoma. Immunohistochemical demonstration of collagen type I, III, IV, and V; laminin; and fibronectin. Acta Neuropathol (Berl) 66:299–305

    Google Scholar 

  8. Kitamura T, Hattori H, Fujita S (1972) Autoradiographic studies on histogenesis of brain macrophages in the mouse. J Neuropathol Exp Neurol 23:11–26

    Google Scholar 

  9. Maxwell WL, Duance VC, Lehto M, Ashhurst DE, Berry M (1984) The distribution of type I, III, IV and V collagens in penetrant lesions of the central nervous system of the rat. Histochem J 16:1219–1229

    Google Scholar 

  10. Nilsson O, Svennerholm L (1982) Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum an infantile and juvenile Gaucher disease. J Neurochem 39:709–718

    Google Scholar 

  11. Nilsson O, Månsson J-E, Håkansson G, Svennerholm L (1982) The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of Gaucher disease. Biochim Biophys Acta 712:452–463

    Google Scholar 

  12. Nilsson O, Håkansson G, Dreborg S, Groth CG, Svennerholm L (1982) Increased cerebroside concentration in plasma and erythrocytes in Gaucher disease: significant differences between type I and type III. Clin Genet 22:274–279

    Google Scholar 

  13. Norman RM (1970) Gaucher's disease. In: Vinken PJ, Bruyn GW (eds) Leukodystrophies and poliodystrophies. Handbook of clinical neurology, vol 10. North-Holland, Amsterdam, pp 151–176

    Google Scholar 

  14. Norton WT, Cammer W, Bloom BR, Gordon S (1976) Neutral proteinases secreted by macrophages degrade basic protein: A possible mechanism of inflammatory demyelination. In: Palo J (ed) Myelination and demyelination. Adv Exp Med Biol 100:365–381

  15. Parkin JL, Brunning RD (1982) Pathology of the Gaucher cell. In: Desnick RJ, Gatt S, Grabowski GA (eds) Gaucher disease: a century of delineation and research. Liss, New York, pp 151–176

    Google Scholar 

  16. Peters A, Palay SL, Webster HdeF (1976) The fine structure of the central nervous system. The neurons and supporting cells. Saunders, Philadelphia London Toronto, pp 295–305

    Google Scholar 

  17. Schelper RL, Adrian EK (1986) Monocytes become macrophages; they do not become microglia: a light and electron microscopic autoradigraphic study using 125-Iododeoxyuridine. J Neuropathol Exp Neurol 45:1–19

    Google Scholar 

  18. Seitelberger F (1964) Über die Gehirnbeteiligung bei der Gaucherschen Krankheit im Kindesalter. Psychiat Nervenkrankh 206:419–440

    Google Scholar 

  19. Sourander P, Conradi NG (1983) Neuropathology of Gaucher disease. In: Vanier MT (ed) Recent progress in neurolipidoses and allied disorders. Collection Fondation Merieux, Lyon, pp 243–249

    Google Scholar 

  20. Sourander P, Hansson H-A, Olsson Y, Svennerholm L (1966) Experimental studies on the pathogenesis of leukodystrophies. II. The effect of sphingolipids on various cell types in cultures from the nervous system. Acta Neuropathol (Berl) 6:231–242

    Google Scholar 

  21. Stenwig AE (1972) The origin of brain macrophages in traumatic lesions. Wallerian degeneration, and retrograde degeneration. J Neuropathol Exp Neurol 31:696–704

    Google Scholar 

  22. Svennerholm L, Dreborg S, Erikson A, Groth GG, Hillborg PO, Håkansson G, Nilsson O, Tibblin E (1982) Gaucher disease of the Norrbottnian type (type III). Phenotypic manifestations. In: Desnick RJ, Gatt S, Grabowski GA (eds) Gaucher disease: a century of delineation and research. Liss, New York, pp 67–94

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Conradi, N.G., Kalimo, H. & Sourander, P. Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease. Acta Neuropathol 75, 385–390 (1988). https://doi.org/10.1007/BF00687792

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00687792

Key words

Navigation